I provide expert witness services in connection with Hatch-Waxman ANDA patent infringement litigation in the area of pharmaceutical technology.

Most recently, my services have been retained by Mylan, where I generated expert reports and was deposed for 7 hours by opposing counsel from Pfizer. I was also involved in the pre-trial federal litigation preparation up until Mylan and Pfizer settled.

A Ph. D. Medicinal Chemist with 11 years industrial experience at Paratek Pharmaceuticals in the discovery and development of novel human therapeutics in the areas of anti-infective, anti-inflammatory and neurodegenerative diseases. I contributed to the development of Omadacycline, a new antibiotic, now in phase III clinical trials.

I have been involved in all aspects of drug research and development from formulation development, synthesis/purification, in-vitro, in-vivo (efficacy and pharmacokinetics), dosing routs, and the management of CROs to support pre-clinical testing.